Commentary on "Impact of high-risk EBV strains on nasopharyngeal carcinoma gene expression."

被引：0
|
作者：
Rajathirajan, Siva Dharshini [1 ]
机构：
[1] Saveetha Inst Med & Tech Sci, Saveetha Med Coll & Hosp, Ctr Global Hlth Res, Kancheepuram, Tamil Nadu, India
来源：
ORAL ONCOLOGY | 2024年 / 159卷
关键词：
D O I：
10.1016/j.oraloncology.2024.107037
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of high-risk EBV strains on nasopharyngeal carcinoma gene expression
    Lim, Chee Yit
    Ng, Gwyneth W. Y.
    Goh, Chuan Keng
    Lee, Melvin Kiang Chua
    Cheong, Ian
    Ooi, Eng Eong
    Liu, Jianjun
    West, Robert B.
    Loh, Kwok Seng
    Tay, Joshua K.
    ORAL ONCOLOGY, 2024, 157
  • [2] Letter to editor regarding "Impact of high-risk EBV strains on nasopharyngeal carcinoma gene expression"
    Sankar, Sathish
    ORAL ONCOLOGY, 2024, 157
  • [3] Prognostic impact of adjuvant chemotherapy in high-risk nasopharyngeal carcinoma patients
    Liu, Yi-Chun
    Wang, Wen-Yi
    Twu, Chih-Wen
    Jiang, Rong-San
    Liang, Kai-Li
    Wu, Ching-Te
    Lin, Po-Ju
    Huang, Jing-Wen
    Hsieh, He-Yuan
    Lin, Jin-Ching
    ORAL ONCOLOGY, 2017, 64 : 15 - 21
  • [4] Prognostic impact of adjuvant chemotherapy in high-risk nasopharyngeal carcinoma patients
    Wu, C.
    Wang, W. Y.
    Twu, C. W.
    Shih, Y. T.
    Lin, P. J.
    Liu, Y. C.
    Lin, J. C.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S309 - S309
  • [5] Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in Taiwan
    Yang, XH
    Diehl, S
    Pfeiffer, R
    Chen, CJ
    Hsu, WL
    Dosemeci, M
    Cheng, YJ
    Sun, B
    Goldstein, AM
    Hildesheim, A
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (04) : 900 - 905
  • [6] High-risk human papillomavirus in nasopharyngeal carcinoma
    Singhi, Aatur D.
    Califano, Joseph
    Westra, William H.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (02): : 213 - 218
  • [7] Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China
    Chen, Hao
    Chen, Shulin
    Lu, Jie
    Wang, Xueping
    Li, Jianpei
    Li, Linfang
    Fu, Jihuan
    Scheper, Thomas
    Meyer, Wolfgang
    Peng, Yu-Hui
    Liu, Wanli
    CANCER PREVENTION RESEARCH, 2017, 10 (09) : 542 - 550
  • [8] A comprehensive analysis of genetic diversity of EBV reveals potential high-risk subtypes associated with nasopharyngeal carcinoma in China
    Xue, Wen-Qiong
    Wang, Tong-Min
    Huang, Jing-Wen
    Zhang, Jiang-Bo
    He, Yong-Qiao
    Wu, Zi-Yi
    Liao, Ying
    Yuan, Lei-Lei
    Mu, Jianbing
    Jia, Wei-Hua
    VIRUS EVOLUTION, 2021, 7 (01)
  • [9] Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma
    Lee, Ching-Chih
    Chu, Sau-Tung
    Chou, Pesus
    AURIS NASUS LARYNX, 2009, 36 (06) : 688 - 694
  • [10] TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma
    Wang, Ya-Qin
    Wu, Dong-Hong
    Wei, Denghui
    Shen, Jia-Yi
    Huang, Zi-Wei
    Liang, Xiao-Yu
    Cho, William C. S.
    Ma, Jun
    Lv, Jiawei
    Chen, Yu-Pei
    SCIENCE ADVANCES, 2023, 9 (01)
12345